B
메타케어
118000KOSPI56.0 / 100
Reference Date: 2026-10-23
Financial Score18.5 / 40
News Sentiment12.5 / 25
Momentum15.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 1.0% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
MetaCare operates across four business segments: Pharmaceuticals, Medical, Investment, and Real Estate Development, with the Pharmaceuticals segment contributing 77.2% of total revenue. The company has expanded its market presence through acquisitions, such as J&N Pharm and H Bio&Co, and achieved 2.8% revenue share from Real Estate Development in 2024.
Number of Employees
32people
Average Salary
65.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
432.00Industry Average 15.000.0Point
28.8x industry avg (risky)
PBR
0.24Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
-0.18Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
20.74Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼0.7% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲52.5% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -4.3% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position6.0Point
52w upper range (63%)
Current 1,296Won52-week high 1,90952-week low 208
1-month return3.0Point
1m 1.01% (flat)
Volume trend6.0Point
Volume increasing
Detailed Disclosure
4 totalPositive 0Neutral 4Negative 0
- Neutral기업가치제고계획(자율공시) (PBR 개선 계획 제출 기업)2026-10-21
- Neutral투자유의안내 (관리종목지정 우려 예고)2026-10-21
- Neutral합병등종료보고서(합병)2026-10-01
- Neutral주요사항보고서(자기전환사채만기전취득결정)2026-09-28